KOR

e-Article

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute
Document Type
Article
Source
In Clinical Breast Cancer August 2015 15(4):251-258
Subject
Language
ISSN
1526-8209